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ABSTRACT
Increased serum levels of oxidised low density lipoprotein (oxLDL) as found in patients with Type 2 diabetes, can induce
severe oxidative stress in exposed cells which then can lead to cell death. Our study aimed to determine how the decreased
cells antioxidant status of pancreatic beta cells induced by oxLDL affects their viability.  We used various concentrations of
CuCl2 oxidised LDL to determine its cytotoxic effect as well as the influence on the antioxidant enzymes activity in HIT-T15
pancreatic beta cells. A significant cellular formation of reactive oxygen species (ROS) was detected within 3 hours incubation
of HIT-T15 pancreatic beta cells with 1.5 mg/mL of oxLDL. The formation of ROS was accompanied by a simultaneously
loss of cellular glutathione. However, a significant reduction in cell viability was only measured after 10 hours incubation
with oxLDL. The enzymatic activities of catalase and peroxidase remained unchanged for 24 hours. These results suggest
that loss of glutathione induced by oxLDL is not sufficient to cause HIT-T15 cell death as they can be still protected from
cytotoxic effects of oxLDL by the other antioxidant defenses such as catalase and peroxidase.
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INTRODUCTION
The progressive dysfunction and destruction of
pancreatic beta-cells are hallmarks of the onset and
progression of type 2 diabetes mellitus (T2DM)
(Plaisance et al., 2016). Chronic excess of
cholesterol and metabolic fuels (such as glucose and
non-esterified palmitate) together with genetic
factors are among the common causes that elicit
beta-cell damage over time (Favre et al., 2011).
High levels of oxLDL are strongly correlated with
obesity-associated metabolic syndrome (Holvoet
et al., 2004) and/or the development of T2DM
(Nakhjavani et al., 2010). Several studies have
shown that low plasma levels of high density
lipoprotein (HDL) together with increased levels of
oxLDL are strongly linked to T2DM (Cubedo et al.,
2015; Rohrer et al., 2004). Oxidative stress caused
by oxLDL was 23% higher in obese and 56% higher
in T2DM patients (Marin et al., 2015). Additionally,
specific antibodies against oxLDL were found in
patients with T2DM while oxLDL receptors were
found in both human and rodent islet beta-
pancreatic cells (Bellomo et al., 1995; Vavuli et al.,
2016).
A previous study showed that exposure of
pancreatic beta cell lines to oxLDL leads to reduced
gene expression with subsequent reduced in insulin
protein production and therefore insulin secretion
(Ceriello, 2000). Kaneto et al. (2010) found that
oxLDL activates mitogen-activated protein kinase
(MAPK) 8 (also known as c-Jun amino terminal
kinase, JNK) which is one of the hallmarks of
oxidative stress. Activation of JNK signaling by
oxLDL leads to decrease in the PDX-1 DNA binding
activity to the insulin promoter which causes
reduction of insulin gene transcription. This event
leads to impaired insulin expression and
consequently pancreatic beta cell dysfunction.
OxLDL also induces the inducible cyclic AMP
repressor (ICER) that silences the expression of
genes containing cAMP response elements (CRE)
and ultimately causes defect in cell insulin genes
expression (Favre et al., 2011). These cumulative
evidences further strengthen the association of
